{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T23:10:04Z","timestamp":1790637004792,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2010,2,10]],"date-time":"2010-02-10T00:00:00Z","timestamp":1265760000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1007\/s11060-010-0126-8","type":"journal-article","created":{"date-parts":[[2010,2,9]],"date-time":"2010-02-09T07:12:31Z","timestamp":1265699551000},"page":"251-260","source":"Crossref","is-referenced-by-count":61,"title":["A prospective evaluation and literature review of levetiracetam use in patients with brain tumors and seizures"],"prefix":"10.1007","volume":"99","author":[{"given":"Justin B.","family":"Usery","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"II","given":"L. Madison","family":"Michael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allen K.","family":"Sills","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher K.","family":"Finch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,2,10]]},"reference":[{"key":"126_CR1","unstructured":"Central Brain Tumor Registry of the United States (2007\u201308) CBTRUS, Chicago"},{"key":"126_CR2","first-page":"477","volume":"148","author":"JB Posner","year":"1992","unstructured":"Posner JB (1992) Management of brain metastases. Rev Neurol (Paris) 148:477\u2013487","journal-title":"Rev Neurol (Paris)"},{"key":"126_CR3","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3322\/canjclin.49.1.8","volume":"49","author":"SH Landis","year":"1999","unstructured":"Landis SH, Murray T, Bolden S, Wingo PA (1999) Cancer statistics, 1999. CA Cancer J Clin 49:8\u201331","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"126_CR4","first-page":"152","volume":"3","author":"FG Davis","year":"2001","unstructured":"Davis FG, Kupelian V, Freels S, McCarthy B, Surawicz T (2001) Prevalence estimates for primary brain tumors in the United States by behavior and major histology groups. Neuro-Oncology 3(3):152\u2013158","journal-title":"Neuro-Oncology"},{"issue":"6","key":"126_CR5","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1097\/00019052-199612000-00005","volume":"9","author":"JG Villemure","year":"1996","unstructured":"Villemure JG, de Tribolet N (1996) Epilepsy in patients with central nervous system tumors. Curr Opin Neurol 9(6):424\u2013428","journal-title":"Curr Opin Neurol"},{"key":"126_CR6","first-page":"106","volume-title":"Cancer of the nervous system","author":"P Wen","year":"1997","unstructured":"Wen P (1997) The diagnosis and management of patients with brain tumors. In: Loeffler JS, Black PM (eds) Cancer of the nervous system. Blackwell Scientific, Boston, pp 106\u2013127"},{"key":"126_CR7","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1001\/archneur.1995.00540310091021","volume":"52","author":"PL Moots","year":"1995","unstructured":"Moots PL, Maciunas RJ, Eisert DR, Parker RA, Laporte K, Abou-Khalil B (1995) The course of seizure disorders in patients with malignant gliomas. Arch Neurol 52:717\u2013724","journal-title":"Arch Neurol"},{"key":"126_CR8","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1111\/j.1528-1157.1999.tb00715.x","volume":"40","author":"HJ Mamon","year":"1999","unstructured":"Mamon HJ, Wen PY, Burns AC, Loeffler JS (1999) Allergic skin reactions to anticonvulsant medications in patients receiving cranial radiation therapy. Epilepsia 40:341\u2013344","journal-title":"Epilepsia"},{"key":"126_CR9","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/0090-3019(81)90227-5","volume":"16","author":"MS Mahaley","year":"1981","unstructured":"Mahaley MS, Dudka L (1981) The role of anticonvulsant medications in the management of patients with anaplastic gliomas. Surg Neurol 16:399\u2013401","journal-title":"Surg Neurol"},{"key":"126_CR10","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1212\/WNL.40.1.158","volume":"40","author":"NA Hagen","year":"1990","unstructured":"Hagen NA, Cirrincione C, Thaler HT et al (1990) The role of radiation therapy following resection of single brain metastasis from melanoma. Neurology 40:158\u2013160","journal-title":"Neurology"},{"key":"126_CR11","first-page":"A1151","volume":"10","author":"S Hung","year":"1999","unstructured":"Hung S, Hilsenbeck S, Feun L (1999) Seizure prophylaxis with phenytoin in patients with brain metastases. Proc Am Soc Clin Oncol 10:A1151","journal-title":"Proc Am Soc Clin Oncol"},{"key":"126_CR12","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1001\/archneur.1995.00540310091021","volume":"52","author":"PL Moots","year":"1995","unstructured":"Moots PL, Maciunas RJ, Eisert DR et al (1995) The course of seizure disorders in patients with malignant gliomas. Arch Neurol 52:717\u2013724","journal-title":"Arch Neurol"},{"key":"126_CR13","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1212\/WNL.46.4.985","volume":"46","author":"MJ Glantz","year":"1996","unstructured":"Glantz MJ, Cole BF, Friedberg MH et al (1996) A randomized, blinded, placebo-controlled trial of divalproex sodium prophylaxis in adults with newly diagnosed brain tumors. Neurology 46:985\u2013991","journal-title":"Neurology"},{"issue":"2","key":"126_CR14","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1017\/S0317167100053361","volume":"30","author":"PA Forsyth","year":"2003","unstructured":"Forsyth PA, Weaver S, Fulton D et al (2003) Prophylactic anticonvulsants in patients with brain tumour. Can J Neurol Sci 30(2):89\u201390","journal-title":"Can J Neurol Sci"},{"issue":"7","key":"126_CR15","first-page":"202","volume":"43","author":"KE VanLandingham","year":"2002","unstructured":"VanLandingham KE, Radtke RA (2002) Use of levetiracetam in patients with brain tumors and intractable partial epilepsy. Epilepsia 43(7):202","journal-title":"Epilepsia"},{"issue":"7","key":"126_CR16","first-page":"297","volume":"43","author":"F Siddiqui","year":"2002","unstructured":"Siddiqui F, Wen P, Dworetzky B, Cabello D, Broomfield EB (2002) Use of levetiracetam in patients with brain tumors. Epilepsia 43(7):297","journal-title":"Epilepsia"},{"issue":"7","key":"126_CR17","first-page":"311","volume":"45","author":"PE Penovich","year":"2004","unstructured":"Penovich PE, Dickens DL, Gates JR et al (2004) Treating seizures due to brain neoplasms: rational new choices. Epilepsia 45(7):311","journal-title":"Epilepsia"},{"issue":"7","key":"126_CR18","first-page":"124","volume":"45","author":"SE Larson","year":"2004","unstructured":"Larson SE, Sirven JI, Drazkowski JF, Zimmerman RS (2004) Efficacy and tolerability of levetiracetam in patients with brain tumors and seizures. Epilepsia 45(7):124","journal-title":"Epilepsia"},{"issue":"1","key":"126_CR19","first-page":"A47","volume":"64","author":"GHJ Stevens","year":"2005","unstructured":"Stevens GHJ, Vogelbaum MA, Suh JH, Peereboom DM, Barnett GH (2005) Levetiracetam use in brain tumor patients. Neurology 64(1):A47\u2013A48","journal-title":"Neurology"},{"issue":"2","key":"126_CR20","first-page":"111","volume":"1","author":"J Brandt","year":"1988","unstructured":"Brandt J, Spencer M, Folstein M (1988) The telephone interview for cognitive status. Neuropsychiatr, Neuropsychol Behav Neurol 1(2):111\u2013117","journal-title":"Neuropsychiatr, Neuropsychol Behav Neurol"},{"issue":"4","key":"126_CR21","first-page":"332","volume":"10","author":"L Ferrucci","year":"1998","unstructured":"Ferrucci L, Del Lungo I, Guralnik JM et al (1998) Is the telephone interview for cognitive status a valid alternative in persons who cannot be evaluated by the mini mental state examination? Aging 10(4):332\u2013338","journal-title":"Aging"},{"key":"126_CR22","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1161\/01.STR.0000141936.36596.1e","volume":"36","author":"AM Naidech","year":"2005","unstructured":"Naidech AM, Kreiter KT, Janjua N et al (2005) Phenytoin exposure is associated with functional and cognitive disability after subarachnoid hemorrhage. Stroke 36:583\u2013587","journal-title":"Stroke"},{"issue":"3","key":"126_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3171\/foc.2007.22.3.13","volume":"22","author":"CE Sanchez","year":"2007","unstructured":"Sanchez CE, Ogilvy CS, Carter BS (2007) Outcomes studies in cerebrovascular neurosurgery. Neurosurg Focus 22(3):1\u201321","journal-title":"Neurosurg Focus"},{"issue":"8","key":"126_CR24","first-page":"191","volume":"46","author":"JP Valeriano","year":"2005","unstructured":"Valeriano JP, Lane CL (2005) Clinical experience with levetiracetam monotherapy in the treatment of epilepsy. Epilepsia 46(8):191","journal-title":"Epilepsia"},{"issue":"1","key":"126_CR25","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s11060-005-9070-4","volume":"78","author":"HB Newton","year":"2006","unstructured":"Newton HB, Goldlust SA, Pearl D (2006) Retrospective analysis of the efficacy and tolerability of levetiracetam in brain tumor patients. J Neurooncol 78(1):99\u2013102","journal-title":"J Neurooncol"},{"issue":"3","key":"126_CR26","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s11060-007-9373-8","volume":"84","author":"HB Newton","year":"2007","unstructured":"Newton HB, Dalton J, Goldlust S, Pearl D (2007) Retrospective analysis of the efficacy and tolerability of levetiracetam in patients with metastatic brain tumors. J Neurooncol 84(3):293\u2013296","journal-title":"J Neurooncol"},{"key":"126_CR27","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.yebeh.2008.01.004","volume":"12","author":"S R\u00fcegg","year":"2008","unstructured":"R\u00fcegg S, Naegelin Y, Hardmeier M, Winkler DT, Marsch S, Fuhr P (2008) Intravenous levetiracetam: treatment experience with the first 50 critically ill patients. Epilepsy Behav 12:477\u2013480","journal-title":"Epilepsy Behav"},{"key":"126_CR28","doi-asserted-by":"publisher","first-page":"227","DOI":"10.3171\/JNS\/2008\/108\/2\/0227","volume":"108","author":"EF Chang","year":"2008","unstructured":"Chang EF, Potts MB, Keles GE et al (2008) Seizure characteristics and control following resection in 332 patients with low-grade gliomas. J Neurosurg 108:227\u2013235","journal-title":"J Neurosurg"},{"key":"126_CR29","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1212\/01.wnl.0000324624.52935.46","volume":"71","author":"TA Milligan","year":"2008","unstructured":"Milligan TA, Hurwitz S, Bromfield EB (2008) Efficacy and tolerability of levetiracetam versus phenytoin after supratentorial neurosurgery. Neurology 71:665\u2013669","journal-title":"Neurology"},{"issue":"3","key":"126_CR30","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s11060-008-9781-4","volume":"93","author":"DA Lim","year":"2009","unstructured":"Lim DA, Tarapore P, Chang E et al (2009) Safety and feasibility of switching from phenytoin to levetiracetam monotherapy for glioma-related seizure control following craniotomy: a randomized phase II pilot study. J Neurooncol 93(3):349\u2013354","journal-title":"J Neurooncol"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-010-0126-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11060-010-0126-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-010-0126-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-010-0126-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,17]],"date-time":"2020-02-17T21:34:04Z","timestamp":1581975244000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11060-010-0126-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2,10]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["126"],"URL":"https:\/\/doi.org\/10.1007\/s11060-010-0126-8","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,2,10]]}}}